Shuttle Pharmaceuticals enters consulting deal with Bowery; $260K fee due after Nasdaq compliance regained

Shuttle Pharmaceuticals Holdings, Inc.

Six-month consulting agreement with Bowery Consulting Group effective March 21, 2025.
Services include research, due diligence, partnership evaluation, and capital raising strategy.
Total fee of $260,000, payable only after Shuttle regains full compliance with Nasdaq Listing Rules.
Agreement aims to support reaching milestones and attract investors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.